Seventh Sense will use the funds to develop its Touch Activated Phlebotomy (TAP) prototypes which can collect higher volume blood samples required for a broad range of field-based diagnostic testing.

During the three-year period of fund, Seventh Sense intends to build a design, develop manufacturing methods and integrate all components into a simple device that can be used with a broad spectrum of point-of-care diagnostic devices.

Global Health Discovery Bill & Melinda Gates Foundation director Chris Wilson said Seventh Sense’s TAP technology provides better care by painlessly, safely and conveniently eliminating conventional barriers to blood collection.

"New and improved diagnostics to use at the point-of-care can help health workers around the world save countless lives," Wilson said.